These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 17080337)

  • 1. Antiepileptic treatment in paediatric oncology--an interdisciplinary challenge.
    Tibussek D; Distelmaier F; Schönberger S; Göbel U; Mayatepek E
    Klin Padiatr; 2006; 218(6):340-9. PubMed ID: 17080337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions between antiepileptic and chemotherapeutic drugs in children with brain tumors: is it time to change treatment?
    Ruggiero A; Rizzo D; Mastrangelo S; Battaglia D; Attinà G; Riccardi R
    Pediatr Blood Cancer; 2010 Feb; 54(2):193-8. PubMed ID: 19731334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Off-label gabapentin masking ictal triphasic waves: case analysis of neuropsychiatric and electrographic correlates.
    Kaufman KR; Struck PJ; Wu B; Wong S
    Epilepsy Behav; 2011 Nov; 22(3):606-9. PubMed ID: 21945412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effectiveness of 10 antiepileptic drugs in older adults with epilepsy.
    Arif H; Buchsbaum R; Pierro J; Whalen M; Sims J; Resor SR; Bazil CW; Hirsch LJ
    Arch Neurol; 2010 Apr; 67(4):408-15. PubMed ID: 20385905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimizing antiepileptic drug treatment in tumoral epilepsy.
    Perucca E
    Epilepsia; 2013 Dec; 54 Suppl 9():97-104. PubMed ID: 24328881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal seizure management in brain tumor patients.
    van Breemen MS; Vecht CJ
    Curr Neurol Neurosci Rep; 2005 May; 5(3):207-13. PubMed ID: 15865886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug interactions between chemotherapeutic regimens and antiepileptics.
    Yap KY; Chui WK; Chan A
    Clin Ther; 2008 Aug; 30(8):1385-407. PubMed ID: 18803983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retention rates of new antiepileptic drugs in localization-related epilepsy: a single-center study.
    Peltola J; Peltola M; Auvinen A; Raitanen J; Fallah M; Keränen T
    Acta Neurol Scand; 2009 Jan; 119(1):55-60. PubMed ID: 18616622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New antiepileptic drugs in practice--how do they perform in the real world?
    Sander JW
    Acta Neurol Scand Suppl; 2005; 181():26-9. PubMed ID: 16238705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety profile of levetiracetam.
    Arroyo S; Crawford P
    Epileptic Disord; 2003 May; 5 Suppl 1():S57-63. PubMed ID: 12915343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seizure characteristics and the use of anti-epileptic drugs in children and young people with brain tumours and epileptic seizures: Analysis of regional paediatric cancer service population.
    Pilotto C; Liu JF; Walker DA; Whitehouse WP
    Seizure; 2018 May; 58():17-21. PubMed ID: 29609145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seizure recurrence and risk factors after antiepilepsy drug withdrawal in children with brain tumors.
    Khan RB; Onar A
    Epilepsia; 2006 Feb; 47(2):375-9. PubMed ID: 16499763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benefit of combination therapy in epilepsy: a review of the preclinical evidence with levetiracetam.
    Kaminski RM; Matagne A; Patsalos PN; Klitgaard H
    Epilepsia; 2009 Mar; 50(3):387-97. PubMed ID: 18627416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Epilepsy in the elderly].
    Yoshino A
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2007 Feb; 27(1):1-8. PubMed ID: 17393773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical efficacy and safety of gabapentin.
    Ramsay RE
    Neurology; 1994 Jun; 44(6 Suppl 5):S23-30; discussion S31-2. PubMed ID: 8022537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management.
    van Breemen MS; Wilms EB; Vecht CJ
    Lancet Neurol; 2007 May; 6(5):421-30. PubMed ID: 17434097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levetiracetam in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center.
    Bootsma HP; Ricker L; Diepman L; Gehring J; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M; Aldenkamp AP
    Epilepsy Behav; 2007 Mar; 10(2):296-303. PubMed ID: 17317325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retention rate of Gabapentin in children with intractable epilepsies at 1 year.
    Mills JK; Ruslan NE; Lewis TG; Mughal K; Ali I; Ugar A; Wassmer E; Siddiqua A; Gupta R; Mordekar SR; Sharma R; Sasidharan L; Whitehouse WP
    Seizure; 2012 Jan; 21(1):28-31. PubMed ID: 21982407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current challenges in the treatment of epilepsy.
    Mattson RH
    Neurology; 1994 Jun; 44(6 Suppl 5):S4-9; discussion S31-2. PubMed ID: 8022538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary efficacy of levetiracetam in monotherapy.
    Ben-Menachem E
    Epileptic Disord; 2003 May; 5 Suppl 1():S51-5. PubMed ID: 12915342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.